logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Unwin, Andrew John
    Born in May 1964
    Individual (48 offsprings)
    Officer
    2022-01-31 ~ now
    OF - Director → CIF 0
    Mr Andrew John Unwin
    Born in May 1964
    Individual (48 offsprings)
    Person with significant control
    2022-01-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

CONTRAST DIAGNOSTICS LTD

Period: 2022-01-31 ~ now
Company number: 13883113
Registered name
CONTRAST DIAGNOSTICS LTD - now
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Average Number of Employees
02024-04-01 ~ 2025-03-31
02023-04-01 ~ 2024-03-31
Property, Plant & Equipment
25,851 GBP2025-03-31
37,259 GBP2024-03-31
Fixed Assets - Investments
16,000 GBP2025-03-31
16,000 GBP2024-03-31
Fixed Assets
41,851 GBP2025-03-31
53,259 GBP2024-03-31
Debtors
3,021 GBP2025-03-31
8,551 GBP2024-03-31
Cash at bank and in hand
4,473 GBP2025-03-31
4,633 GBP2024-03-31
Current Assets
7,494 GBP2025-03-31
13,184 GBP2024-03-31
Creditors
Current
179,633 GBP2025-03-31
161,156 GBP2024-03-31
Net Current Assets/Liabilities
-172,139 GBP2025-03-31
-147,972 GBP2024-03-31
Total Assets Less Current Liabilities
-130,288 GBP2025-03-31
-94,713 GBP2024-03-31
Equity
Called up share capital
1,000 GBP2025-03-31
1,000 GBP2024-03-31
Retained earnings (accumulated losses)
-131,288 GBP2025-03-31
-95,713 GBP2024-03-31
Equity
-130,288 GBP2025-03-31
-94,713 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
55,062 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
29,211 GBP2025-03-31
17,803 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
11,408 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
25,851 GBP2025-03-31
37,259 GBP2024-03-31
Investments in Group Undertakings
Cost valuation
16,000 GBP2024-03-31
Investments in Group Undertakings
16,000 GBP2025-03-31
16,000 GBP2024-03-31
Other Debtors
Current, Amounts falling due within one year
3,021 GBP2025-03-31
8,551 GBP2024-03-31
Trade Creditors/Trade Payables
Current
-133 GBP2025-03-31
5,961 GBP2024-03-31
Other Creditors
Current
35,070 GBP2025-03-31
45,877 GBP2024-03-31

  • CONTRAST DIAGNOSTICS LTD
    Info
    Registered number 13883113
    88 East Stand Highbury Stadium Square, London, London N5 1FF
    PRIVATE LIMITED COMPANY incorporated on 2022-01-31 (4 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-01-31
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.